Showing results (771-780 of 1,246) with videos related to
Sort By:
Pageof 125
Experimental Oncology|October 8, 2025
LYMPHOCYTE SUBSET DISTRIBUTION AFTER COMBINED CHEMO- AND RADIOTHERAPY IN PATIENTS WITH CANCER OF THE ORAL CAVITY, OROPHARYNX, AND LARYNGOPHARYNXM Vorobyov, L Zvarych, D BazykaExperimental Oncology|October 8, 2025
PREVENTION OF PACLITAXEL-INDUCED MOTOR NEUROPATHY OF FIBULAR AND TIBIAL NERVES WITH ALPHA-LIPOIC ACID AND IPIDACRIN HYDROCHLORIDE IN BREAST CANCER PATIENTSI Holotiuk, A Kryzhanivska, S Holotiuk, et al.Experimental Oncology|October 8, 2025
COMPARATIVE STUDY OF SODIUM OXAMATE AND METFORMIN CYTOTOXICITY AGAINST LEWIS LUNG CARCINOMA CELLS UNDER ANCHORAGE-INDEPENDENT GROWTHD Kolesnik, Y Stepanov, I Prokhorova, et al.Experimental Oncology|January 11, 2013
Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?W Naumnik, B Naumnik, K Niewiarowska, et al.Experimental Oncology|January 11, 2013
Sensitivity of human laryngeal squamous cell carcinoma Hep-2 to metrotexate chemoterapyA L S Galbiatti, H C Caldas, J A Padovani, et al.Experimental Oncology|January 11, 2013
Lenalidomide-based combined therapy induced alterations in serum proteins of multiple myeloma patient: a follow-up case report and overview of the literatureC S Senthilkumar, N GaneshExperimental Oncology|September 30, 2014
Tissue eosinophilia in head and neck squamous neoplasia: an updateM Jain, S Kasetty, S Khan, et al.Experimental Oncology|September 30, 2014
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumorI G Tkalia, L I Vorobyova, A N Grabovoy, et al.Experimental Oncology|September 30, 2014
The phospho-c-Jun (Ser63) content in mucosa cells under experimental development of gastric cancerM O Tymoshenko, O O Kravchenko, O V Sokur, et al.Experimental Oncology|September 30, 2014
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatinV F Chekhun, Y V Lozovska, A P Burlaka, et al.Pageof 125